Risk factors and the level of laboratory biomarkers abnormalities amongst COVID-19 admitted patients with acute kidney injury: A retrospective cross-sectional study
- 17 July 2024
- journal article
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 12 (1) , 15
Abstract
Introduction: Infection with SARS-CoV-2 might lead to severe acute kidney injury (AKI) with high morbidity and mortality. Various incidence rates of AKI have been reported among hospitalized patients with COVID-19. Our study aimed to investigate the risk factors associated with AKI in hospitalized COVID-19 patients and the relevant changes in their blood biomarkers compared to COVID-19 patients without AKI. Methods: In this retrospective cross-sectional study, 262 COVID-19-confirmed hospitalized patients were enrolled in the Department of Internal Medicine at Bohlool teaching hospital, Iran, from September 2019 to January 2020. Then, the information related to demographics, medical history, comorbid conditions, and clinical and laboratory findings was documented. Patients were categorized into two groups: Patients without AKI and patients with AKI. Results: We detected 130 (49.6%) patients with AKI among the total number of 262 patients admitted with COVID-19. A total of 68 (25.9%) patients had severe disease, and fever (47.1%) was the most common presenting symptom. Older age, comorbid cardiovascular diseases (CVD), and severe COVID-19 were significantly associated with higher risk of AKI. Abnormal levels of white blood cells (WBC), neutrophil count, hemoglobin (Hb), prothrombin time (PT), international normalized ratio (INR), D-dimer, C-reactive protein (CRP), alkaline phosphatase (ALP), direct bilirubin, blood urea nitrogen (BUN), creatinine, potassium (K), ferritin (in female patients), albumin (Alb), pH, and oxygen saturation (SPO2 ) was significantly associated with a higher risk of developing AKI in COVID-19 patients. Conclusion: AKI was a common condition among COVID-19 patients in our sample. Our study confirms the effect of COVID-19 on the developing of AKI. The association between blood biomarkers, including hematologic and inflammatory markers indicate their potential role in the impairment of kidney function.Keywords
This publication has 27 references indexed in Scilit:
- Systolic dysfunction and complete heart block as complications of fulminant myocarditis in a recovered COVID-19 patientJournal of Cardiology Cases, 2021
- Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus ConferenceKidney International, 2021
- Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review2021
- Elevated D-Dimer Is Associated with Multiple Clinical Outcomes in Hospitalized Covid-19 Patients: a Retrospective Cohort StudySN Comprehensive Clinical Medicine, 2020
- Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case reportJournal of Neuroimmunology, 2020
- Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19Anaesthesia Critical Care & Pain Medicine, 2020
- Acute kidney injury in patients hospitalized with COVID-19Kidney International, 2020
- Kidney disease is associated with in-hospital death of patients with COVID-19Kidney International, 2020
- Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) ConferenceKidney International, 2020
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infectionFrontiers of Medicine, 2020